Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Prev Post 5 Biggest Blockchain ETFs in 2025 June 4, 2025 Next Post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case June 4, 2025 Related Posts Copper Quest Announces Securities for Debt Settlement February 13, 2026 Deep Space Energy Secures US$1.1 Million to Advance Lunar Power and Satellite Resilience Goals February 13, 2026 Albemarle Lifts Lithium Demand Forecast as Energy Storage Surges February 13, 2026
Deep Space Energy Secures US$1.1 Million to Advance Lunar Power and Satellite Resilience Goals February 13, 2026